Glycoprotein 130 improves repressor element‑1 silencing transcription factor‑related axon regenerative capacity in peripheral nerves with aging
Molecular Medicine Reports · 2025
DOI: 10.3892/mmr.2025.13486 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Medicine Reports, 2025. Verfasst von So Kawakita und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine for Orthopedics and Motor Organ, Juntendo University Graduate School of Medicine, Tokyo 113‑8421, Japan. Hauptthemen laut MEDLINE: Nerve Regeneration, Axons, Aging, Repressor Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Axon regenerative capacity diminishes with aging and differences in the condition of peripheral nerves between young and elderly individuals have been reported. However, the underlying pathology remains unclear. The expression of repressor element‑1 silencing transcription factor (REST) increases with age and is reported to suppress axon regeneration. The present study investigated the pathology and potential treatment of reduced axon regenerative capacity using REST‑regulated cells and a mouse model. This study examined the molecular expression of the janus kinase 1 (JAK1)/signal transducer and activator of transcription 3 (STAT3) pathway, which is involved in growth‑associated protein 43 (GAP43) expression. In REST‑overexpressed (REST‑OE), glycoprotein 130 (GP130), JAK1 and phosphorylated STAT3 (p‑STAT3) expression was decreased compared with the control (GP130, P=0.004; JAK1, P=0.038; pSTAT3, P=0.015). On the other hand, in REST‑low expressed (siREST), GP130, JAK1 and pSTAT3 expression was increased compared with the control (GP130, P=0.004; JAK1, P=0.003; pSTAT3, P=0.033). It suggested that GP130 plays an important role. Therefore, GP130 agonist was administered to REST‑OE and aged mice and resulted in a significant increase in GAP43 expression (REST‑OE: Protein P=0.018, mRNA P=0.040; aged mice: Protein P=0.016, mRNA P=0.013). The results of this study suggest that the pathology of reduction in peripheral nerve axon regenerative capacity is inhibited by age‑related increase in REST expression, which leads to decreased GP130 expression and inhibition of JAK1/STAT3 pathway activity. These findings suggest that regulating GP130 expression may improve axon regenerative capacity by aging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine for Orthopedics and Motor Organ, Juntendo University Graduate School of Medicine, Tokyo 113‑8421, Japan.
- Department of Neurology, Graduate School of Medical Sciences, University of Yamanashi, Chuo, Yamanashi 409‑3898, Japan.
- Department of Orthopedics, Juntendo University Faculty of Medicine, Tokyo 113‑8421, Japan.
- Department of Neurology, Juntendo University Faculty of Medicine, Tokyo 113‑8421, Japan.
Zitieren
APA
Kawakita, S., Naito, K., Kubota, D., Ueno, Y., Negishi-Koga, T., Yamamoto, Y., Suzuki, T., Imazu, N., Kawamura, K., Hattori, N., & Ishijima, M. (2025). Glycoprotein 130 improves repressor element‑1 silencing transcription factor‑related axon regenerative capacity in peripheral nerves with aging. Molecular Medicine Reports. https://doi.org/10.3892/mmr.2025.13486
Vancouver
Kawakita S, Naito K, Kubota D, Ueno Y, Negishi-Koga T, Yamamoto Y, et al. Glycoprotein 130 improves repressor element‑1 silencing transcription factor‑related axon regenerative capacity in peripheral nerves with aging. Molecular Medicine Reports. 2025. doi:10.3892/mmr.2025.13486
BibTeX
@article{Kawakita2025,
author = {Kawakita, So and Naito, Kiyohito and Kubota, Daisuke and Ueno, Yuji and Negishi-Koga, Takako and Yamamoto, Yasuhiro and Suzuki, Takamaru and Imazu, Norizumi and Kawamura, Kenjiro and Hattori, Nobutaka and Ishijima, Muneaki},
title = {Glycoprotein 130 improves repressor element‑1 silencing transcription factor‑related axon regenerative capacity in peripheral nerves with aging},
journal = {Molecular Medicine Reports},
year = {2025},
doi = {10.3892/mmr.2025.13486}
}
EUVIMED